Review



recombinant human vascular endothelial growth factor 165  (TargetMol)


Bioz Verified Symbol TargetMol is a verified supplier
Bioz Manufacturer Symbol TargetMol manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    TargetMol recombinant human vascular endothelial growth factor 165
    Recombinant Human Vascular Endothelial Growth Factor 165, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tmp/VEGF165+Protein%2C+Human%2C+Recombinant/pm42176839-49-24-32
    Average 94 stars, based on 1 article reviews
    recombinant human vascular endothelial growth factor 165 - by Bioz Stars, 2026-10
    94/100 stars

    Images

    Related Articles

    other:

    Article Title: N-butylphthalide (NBP) and ligustrazine (TMP) triazole hybrids target the KEAP1-NRF2 pathway to inhibit ferroptosis and exert brain neuroprotectivity
    Article Snippet: NBP and TMP (Target Mol.

    Article Title: Design, synthesis, and neuroprotective evaluation of chiral butylphthalide-ligustrazine hybrids via the Keap1-Nrf2 pathway in ischemic stroke.
    Article Snippet: As a racemate, 3-n-butylphthalide (NBP) can be separated into its Sand R-enantiomers, with S-NBP reported to exhibit superior bioactivity.. To develop more potent anti-stroke agents with enhanced bioavailability, we therefore employed S-NBP as the lead compound.. Through structural modification and hybridization with ligustrazine (TMP), 20 novel S-NBP-TMP hybrids were designed and synthesized.




    Similar Products

    94
    BOC Sciences dmso
    ( A ) 4 dpci <t>DMSO-treated</t> <t>and</t> <t>TGF-β</t> inhibitor-treated ventricular sections stained for MyHC (CMs, green), mCherry (macrophages, magenta), and DAPI (DNA, blue). Arrowheads point to mpeg1.1 :mCherryF + cells. ( B ) Number of mpeg1.1 :mCherryF + cells per mm 2 injured area in DMSO-treated ( n = 6) and TGFβ inhibitor-treated ( n = 5) ventricles at 4 dpci. ( C ) RT-qPCR analysis of tnfa, il6 and il1b mRNA levels in control (Ctrl) ( n = 4) and TGF-β inhibitor-treated ( n = 5) cryoinjured ventricles at 4 dpci. ( D ) RT-qPCR analysis of ccl20a.3 and cdaa mRNA levels in control (Ctrl) ( n = 5) and TGFβ inhibitor-treated ( n = 5) cryoinjured ventricles at 4 dpci. ( E ) 4 dpci sulf1 +/+ , sulf1 +/+ dexamethasone-treated (DEX), sulf1 −/− and sulf1 −/− dexamethasone-treated ventricular sections stained for pSmad3 (magenta) and DAPI (DNA, blue). Arrowheads point to pSmad3 + cells. ( F ) Number of pSmad3 + cells per mm 2 injured area in sulf1 +/+ ( n = 4), sulf1 +/+ dexamethasone-treated ( n = 4), sulf1 −/− ( n = 5) and sulf1 −/− dexamethasone-treated ( n = 6) ventricles at 4 dpci. ( G ) 30 dpci sulf1 −/− DMSO-treated and sulf1 −/− dexamethasone-treated ventricular sections stained with AFOG for muscle (yellow), collagen (blue), and fibrin (red). ( H ) Percentage representation of groups of different fibrotic area sizes at 30 dpci for cryoinjured sulf1 −/− DMSO-treated ( n = 6) and sulf1 −/− dexamethasone-treated ( n = 5) ventricles. Black dotted lines delineate the area with collagen and fibrin deposits. ( I ) Percentage of collagen/fibrin in fibrotic area in sulf1 −/− DMSO-treated ( n = 6) and sulf1 −/− dexamethasone-treated ( n = 5) ventricles at 30 dpci. Scale bars: 100 µm. White dashed lines delineate the injured area. Statistical tests: Nonparametric Mann–Whitney test ( C , D ), Student’s t test ( B , F , I ). For the boxplots, the center line indicates the median; the box bounds represent the 25th and 75th percentiles; the whiskers extend to the most extreme data points; and each point represents an independent measurement. .
    Dmso, supplied by BOC Sciences, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tmp/Di-TMP+(Ditrimethylolpropane)+Plant/pmc13649710-439-23-20
    Average 94 stars, based on 1 article reviews
    dmso - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress tmp
    ( A ) 4 dpci <t>DMSO-treated</t> <t>and</t> <t>TGF-β</t> inhibitor-treated ventricular sections stained for MyHC (CMs, green), mCherry (macrophages, magenta), and DAPI (DNA, blue). Arrowheads point to mpeg1.1 :mCherryF + cells. ( B ) Number of mpeg1.1 :mCherryF + cells per mm 2 injured area in DMSO-treated ( n = 6) and TGFβ inhibitor-treated ( n = 5) ventricles at 4 dpci. ( C ) RT-qPCR analysis of tnfa, il6 and il1b mRNA levels in control (Ctrl) ( n = 4) and TGF-β inhibitor-treated ( n = 5) cryoinjured ventricles at 4 dpci. ( D ) RT-qPCR analysis of ccl20a.3 and cdaa mRNA levels in control (Ctrl) ( n = 5) and TGFβ inhibitor-treated ( n = 5) cryoinjured ventricles at 4 dpci. ( E ) 4 dpci sulf1 +/+ , sulf1 +/+ dexamethasone-treated (DEX), sulf1 −/− and sulf1 −/− dexamethasone-treated ventricular sections stained for pSmad3 (magenta) and DAPI (DNA, blue). Arrowheads point to pSmad3 + cells. ( F ) Number of pSmad3 + cells per mm 2 injured area in sulf1 +/+ ( n = 4), sulf1 +/+ dexamethasone-treated ( n = 4), sulf1 −/− ( n = 5) and sulf1 −/− dexamethasone-treated ( n = 6) ventricles at 4 dpci. ( G ) 30 dpci sulf1 −/− DMSO-treated and sulf1 −/− dexamethasone-treated ventricular sections stained with AFOG for muscle (yellow), collagen (blue), and fibrin (red). ( H ) Percentage representation of groups of different fibrotic area sizes at 30 dpci for cryoinjured sulf1 −/− DMSO-treated ( n = 6) and sulf1 −/− dexamethasone-treated ( n = 5) ventricles. Black dotted lines delineate the area with collagen and fibrin deposits. ( I ) Percentage of collagen/fibrin in fibrotic area in sulf1 −/− DMSO-treated ( n = 6) and sulf1 −/− dexamethasone-treated ( n = 5) ventricles at 30 dpci. Scale bars: 100 µm. White dashed lines delineate the injured area. Statistical tests: Nonparametric Mann–Whitney test ( C , D ), Student’s t test ( B , F , I ). For the boxplots, the center line indicates the median; the box bounds represent the 25th and 75th percentiles; the whiskers extend to the most extreme data points; and each point represents an independent measurement. .
    Tmp, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tmp/Ligustrazine/pmc12992534-74-0-14
    Average 94 stars, based on 1 article reviews
    tmp - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    94
    TargetMol recombinant human vascular endothelial growth factor 165
    ( A ) 4 dpci <t>DMSO-treated</t> <t>and</t> <t>TGF-β</t> inhibitor-treated ventricular sections stained for MyHC (CMs, green), mCherry (macrophages, magenta), and DAPI (DNA, blue). Arrowheads point to mpeg1.1 :mCherryF + cells. ( B ) Number of mpeg1.1 :mCherryF + cells per mm 2 injured area in DMSO-treated ( n = 6) and TGFβ inhibitor-treated ( n = 5) ventricles at 4 dpci. ( C ) RT-qPCR analysis of tnfa, il6 and il1b mRNA levels in control (Ctrl) ( n = 4) and TGF-β inhibitor-treated ( n = 5) cryoinjured ventricles at 4 dpci. ( D ) RT-qPCR analysis of ccl20a.3 and cdaa mRNA levels in control (Ctrl) ( n = 5) and TGFβ inhibitor-treated ( n = 5) cryoinjured ventricles at 4 dpci. ( E ) 4 dpci sulf1 +/+ , sulf1 +/+ dexamethasone-treated (DEX), sulf1 −/− and sulf1 −/− dexamethasone-treated ventricular sections stained for pSmad3 (magenta) and DAPI (DNA, blue). Arrowheads point to pSmad3 + cells. ( F ) Number of pSmad3 + cells per mm 2 injured area in sulf1 +/+ ( n = 4), sulf1 +/+ dexamethasone-treated ( n = 4), sulf1 −/− ( n = 5) and sulf1 −/− dexamethasone-treated ( n = 6) ventricles at 4 dpci. ( G ) 30 dpci sulf1 −/− DMSO-treated and sulf1 −/− dexamethasone-treated ventricular sections stained with AFOG for muscle (yellow), collagen (blue), and fibrin (red). ( H ) Percentage representation of groups of different fibrotic area sizes at 30 dpci for cryoinjured sulf1 −/− DMSO-treated ( n = 6) and sulf1 −/− dexamethasone-treated ( n = 5) ventricles. Black dotted lines delineate the area with collagen and fibrin deposits. ( I ) Percentage of collagen/fibrin in fibrotic area in sulf1 −/− DMSO-treated ( n = 6) and sulf1 −/− dexamethasone-treated ( n = 5) ventricles at 30 dpci. Scale bars: 100 µm. White dashed lines delineate the injured area. Statistical tests: Nonparametric Mann–Whitney test ( C , D ), Student’s t test ( B , F , I ). For the boxplots, the center line indicates the median; the box bounds represent the 25th and 75th percentiles; the whiskers extend to the most extreme data points; and each point represents an independent measurement. .
    Recombinant Human Vascular Endothelial Growth Factor 165, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tmp/VEGF165+Protein%2C+Human%2C+Recombinant/pm42176839-49-24-32
    Average 94 stars, based on 1 article reviews
    recombinant human vascular endothelial growth factor 165 - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    86
    Liofilchem tmp smx
    ( A ) 4 dpci <t>DMSO-treated</t> <t>and</t> <t>TGF-β</t> inhibitor-treated ventricular sections stained for MyHC (CMs, green), mCherry (macrophages, magenta), and DAPI (DNA, blue). Arrowheads point to mpeg1.1 :mCherryF + cells. ( B ) Number of mpeg1.1 :mCherryF + cells per mm 2 injured area in DMSO-treated ( n = 6) and TGFβ inhibitor-treated ( n = 5) ventricles at 4 dpci. ( C ) RT-qPCR analysis of tnfa, il6 and il1b mRNA levels in control (Ctrl) ( n = 4) and TGF-β inhibitor-treated ( n = 5) cryoinjured ventricles at 4 dpci. ( D ) RT-qPCR analysis of ccl20a.3 and cdaa mRNA levels in control (Ctrl) ( n = 5) and TGFβ inhibitor-treated ( n = 5) cryoinjured ventricles at 4 dpci. ( E ) 4 dpci sulf1 +/+ , sulf1 +/+ dexamethasone-treated (DEX), sulf1 −/− and sulf1 −/− dexamethasone-treated ventricular sections stained for pSmad3 (magenta) and DAPI (DNA, blue). Arrowheads point to pSmad3 + cells. ( F ) Number of pSmad3 + cells per mm 2 injured area in sulf1 +/+ ( n = 4), sulf1 +/+ dexamethasone-treated ( n = 4), sulf1 −/− ( n = 5) and sulf1 −/− dexamethasone-treated ( n = 6) ventricles at 4 dpci. ( G ) 30 dpci sulf1 −/− DMSO-treated and sulf1 −/− dexamethasone-treated ventricular sections stained with AFOG for muscle (yellow), collagen (blue), and fibrin (red). ( H ) Percentage representation of groups of different fibrotic area sizes at 30 dpci for cryoinjured sulf1 −/− DMSO-treated ( n = 6) and sulf1 −/− dexamethasone-treated ( n = 5) ventricles. Black dotted lines delineate the area with collagen and fibrin deposits. ( I ) Percentage of collagen/fibrin in fibrotic area in sulf1 −/− DMSO-treated ( n = 6) and sulf1 −/− dexamethasone-treated ( n = 5) ventricles at 30 dpci. Scale bars: 100 µm. White dashed lines delineate the injured area. Statistical tests: Nonparametric Mann–Whitney test ( C , D ), Student’s t test ( B , F , I ). For the boxplots, the center line indicates the median; the box bounds represent the 25th and 75th percentiles; the whiskers extend to the most extreme data points; and each point represents an independent measurement. .
    Tmp Smx, supplied by Liofilchem, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tmp/smx+tmp/pm42066543-43-1-15
    Average 86 stars, based on 1 article reviews
    tmp smx - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    86
    Fisher Scientific trimethoprim tmp
    ( A ) 4 dpci <t>DMSO-treated</t> <t>and</t> <t>TGF-β</t> inhibitor-treated ventricular sections stained for MyHC (CMs, green), mCherry (macrophages, magenta), and DAPI (DNA, blue). Arrowheads point to mpeg1.1 :mCherryF + cells. ( B ) Number of mpeg1.1 :mCherryF + cells per mm 2 injured area in DMSO-treated ( n = 6) and TGFβ inhibitor-treated ( n = 5) ventricles at 4 dpci. ( C ) RT-qPCR analysis of tnfa, il6 and il1b mRNA levels in control (Ctrl) ( n = 4) and TGF-β inhibitor-treated ( n = 5) cryoinjured ventricles at 4 dpci. ( D ) RT-qPCR analysis of ccl20a.3 and cdaa mRNA levels in control (Ctrl) ( n = 5) and TGFβ inhibitor-treated ( n = 5) cryoinjured ventricles at 4 dpci. ( E ) 4 dpci sulf1 +/+ , sulf1 +/+ dexamethasone-treated (DEX), sulf1 −/− and sulf1 −/− dexamethasone-treated ventricular sections stained for pSmad3 (magenta) and DAPI (DNA, blue). Arrowheads point to pSmad3 + cells. ( F ) Number of pSmad3 + cells per mm 2 injured area in sulf1 +/+ ( n = 4), sulf1 +/+ dexamethasone-treated ( n = 4), sulf1 −/− ( n = 5) and sulf1 −/− dexamethasone-treated ( n = 6) ventricles at 4 dpci. ( G ) 30 dpci sulf1 −/− DMSO-treated and sulf1 −/− dexamethasone-treated ventricular sections stained with AFOG for muscle (yellow), collagen (blue), and fibrin (red). ( H ) Percentage representation of groups of different fibrotic area sizes at 30 dpci for cryoinjured sulf1 −/− DMSO-treated ( n = 6) and sulf1 −/− dexamethasone-treated ( n = 5) ventricles. Black dotted lines delineate the area with collagen and fibrin deposits. ( I ) Percentage of collagen/fibrin in fibrotic area in sulf1 −/− DMSO-treated ( n = 6) and sulf1 −/− dexamethasone-treated ( n = 5) ventricles at 30 dpci. Scale bars: 100 µm. White dashed lines delineate the injured area. Statistical tests: Nonparametric Mann–Whitney test ( C , D ), Student’s t test ( B , F , I ). For the boxplots, the center line indicates the median; the box bounds represent the 25th and 75th percentiles; the whiskers extend to the most extreme data points; and each point represents an independent measurement. .
    Trimethoprim Tmp, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tmp/trimethoprim/10__1002_slash_cmtd__202500165-136-0-5
    Average 86 stars, based on 1 article reviews
    trimethoprim tmp - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    91
    Sterlitech corporation transmembrane pressure tmp
    ( A ) 4 dpci <t>DMSO-treated</t> <t>and</t> <t>TGF-β</t> inhibitor-treated ventricular sections stained for MyHC (CMs, green), mCherry (macrophages, magenta), and DAPI (DNA, blue). Arrowheads point to mpeg1.1 :mCherryF + cells. ( B ) Number of mpeg1.1 :mCherryF + cells per mm 2 injured area in DMSO-treated ( n = 6) and TGFβ inhibitor-treated ( n = 5) ventricles at 4 dpci. ( C ) RT-qPCR analysis of tnfa, il6 and il1b mRNA levels in control (Ctrl) ( n = 4) and TGF-β inhibitor-treated ( n = 5) cryoinjured ventricles at 4 dpci. ( D ) RT-qPCR analysis of ccl20a.3 and cdaa mRNA levels in control (Ctrl) ( n = 5) and TGFβ inhibitor-treated ( n = 5) cryoinjured ventricles at 4 dpci. ( E ) 4 dpci sulf1 +/+ , sulf1 +/+ dexamethasone-treated (DEX), sulf1 −/− and sulf1 −/− dexamethasone-treated ventricular sections stained for pSmad3 (magenta) and DAPI (DNA, blue). Arrowheads point to pSmad3 + cells. ( F ) Number of pSmad3 + cells per mm 2 injured area in sulf1 +/+ ( n = 4), sulf1 +/+ dexamethasone-treated ( n = 4), sulf1 −/− ( n = 5) and sulf1 −/− dexamethasone-treated ( n = 6) ventricles at 4 dpci. ( G ) 30 dpci sulf1 −/− DMSO-treated and sulf1 −/− dexamethasone-treated ventricular sections stained with AFOG for muscle (yellow), collagen (blue), and fibrin (red). ( H ) Percentage representation of groups of different fibrotic area sizes at 30 dpci for cryoinjured sulf1 −/− DMSO-treated ( n = 6) and sulf1 −/− dexamethasone-treated ( n = 5) ventricles. Black dotted lines delineate the area with collagen and fibrin deposits. ( I ) Percentage of collagen/fibrin in fibrotic area in sulf1 −/− DMSO-treated ( n = 6) and sulf1 −/− dexamethasone-treated ( n = 5) ventricles at 30 dpci. Scale bars: 100 µm. White dashed lines delineate the injured area. Statistical tests: Nonparametric Mann–Whitney test ( C , D ), Student’s t test ( B , F , I ). For the boxplots, the center line indicates the median; the box bounds represent the 25th and 75th percentiles; the whiskers extend to the most extreme data points; and each point represents an independent measurement. .
    Transmembrane Pressure Tmp, supplied by Sterlitech corporation, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tmp/TAMI+Ceramic+Membrane+Complete+Disc-Holder/10__1016_slash_j__ceja__2026__101171-109-16-12
    Average 91 stars, based on 1 article reviews
    transmembrane pressure tmp - by Bioz Stars, 2026-10
    91/100 stars
      Buy from Supplier

    94
    MedChemExpress trimethylphosphate tmp
    ( A ) 4 dpci <t>DMSO-treated</t> <t>and</t> <t>TGF-β</t> inhibitor-treated ventricular sections stained for MyHC (CMs, green), mCherry (macrophages, magenta), and DAPI (DNA, blue). Arrowheads point to mpeg1.1 :mCherryF + cells. ( B ) Number of mpeg1.1 :mCherryF + cells per mm 2 injured area in DMSO-treated ( n = 6) and TGFβ inhibitor-treated ( n = 5) ventricles at 4 dpci. ( C ) RT-qPCR analysis of tnfa, il6 and il1b mRNA levels in control (Ctrl) ( n = 4) and TGF-β inhibitor-treated ( n = 5) cryoinjured ventricles at 4 dpci. ( D ) RT-qPCR analysis of ccl20a.3 and cdaa mRNA levels in control (Ctrl) ( n = 5) and TGFβ inhibitor-treated ( n = 5) cryoinjured ventricles at 4 dpci. ( E ) 4 dpci sulf1 +/+ , sulf1 +/+ dexamethasone-treated (DEX), sulf1 −/− and sulf1 −/− dexamethasone-treated ventricular sections stained for pSmad3 (magenta) and DAPI (DNA, blue). Arrowheads point to pSmad3 + cells. ( F ) Number of pSmad3 + cells per mm 2 injured area in sulf1 +/+ ( n = 4), sulf1 +/+ dexamethasone-treated ( n = 4), sulf1 −/− ( n = 5) and sulf1 −/− dexamethasone-treated ( n = 6) ventricles at 4 dpci. ( G ) 30 dpci sulf1 −/− DMSO-treated and sulf1 −/− dexamethasone-treated ventricular sections stained with AFOG for muscle (yellow), collagen (blue), and fibrin (red). ( H ) Percentage representation of groups of different fibrotic area sizes at 30 dpci for cryoinjured sulf1 −/− DMSO-treated ( n = 6) and sulf1 −/− dexamethasone-treated ( n = 5) ventricles. Black dotted lines delineate the area with collagen and fibrin deposits. ( I ) Percentage of collagen/fibrin in fibrotic area in sulf1 −/− DMSO-treated ( n = 6) and sulf1 −/− dexamethasone-treated ( n = 5) ventricles at 30 dpci. Scale bars: 100 µm. White dashed lines delineate the injured area. Statistical tests: Nonparametric Mann–Whitney test ( C , D ), Student’s t test ( B , F , I ). For the boxplots, the center line indicates the median; the box bounds represent the 25th and 75th percentiles; the whiskers extend to the most extreme data points; and each point represents an independent measurement. .
    Trimethylphosphate Tmp, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tmp/Trimethyl+phosphate/10__1016_slash_j__colsurfa__2026__140609-192-22-43
    Average 94 stars, based on 1 article reviews
    trimethylphosphate tmp - by Bioz Stars, 2026-10
    94/100 stars
      Buy from Supplier

    86
    Tokyo Chemical Industry tmp
    ( A ) 4 dpci <t>DMSO-treated</t> <t>and</t> <t>TGF-β</t> inhibitor-treated ventricular sections stained for MyHC (CMs, green), mCherry (macrophages, magenta), and DAPI (DNA, blue). Arrowheads point to mpeg1.1 :mCherryF + cells. ( B ) Number of mpeg1.1 :mCherryF + cells per mm 2 injured area in DMSO-treated ( n = 6) and TGFβ inhibitor-treated ( n = 5) ventricles at 4 dpci. ( C ) RT-qPCR analysis of tnfa, il6 and il1b mRNA levels in control (Ctrl) ( n = 4) and TGF-β inhibitor-treated ( n = 5) cryoinjured ventricles at 4 dpci. ( D ) RT-qPCR analysis of ccl20a.3 and cdaa mRNA levels in control (Ctrl) ( n = 5) and TGFβ inhibitor-treated ( n = 5) cryoinjured ventricles at 4 dpci. ( E ) 4 dpci sulf1 +/+ , sulf1 +/+ dexamethasone-treated (DEX), sulf1 −/− and sulf1 −/− dexamethasone-treated ventricular sections stained for pSmad3 (magenta) and DAPI (DNA, blue). Arrowheads point to pSmad3 + cells. ( F ) Number of pSmad3 + cells per mm 2 injured area in sulf1 +/+ ( n = 4), sulf1 +/+ dexamethasone-treated ( n = 4), sulf1 −/− ( n = 5) and sulf1 −/− dexamethasone-treated ( n = 6) ventricles at 4 dpci. ( G ) 30 dpci sulf1 −/− DMSO-treated and sulf1 −/− dexamethasone-treated ventricular sections stained with AFOG for muscle (yellow), collagen (blue), and fibrin (red). ( H ) Percentage representation of groups of different fibrotic area sizes at 30 dpci for cryoinjured sulf1 −/− DMSO-treated ( n = 6) and sulf1 −/− dexamethasone-treated ( n = 5) ventricles. Black dotted lines delineate the area with collagen and fibrin deposits. ( I ) Percentage of collagen/fibrin in fibrotic area in sulf1 −/− DMSO-treated ( n = 6) and sulf1 −/− dexamethasone-treated ( n = 5) ventricles at 30 dpci. Scale bars: 100 µm. White dashed lines delineate the injured area. Statistical tests: Nonparametric Mann–Whitney test ( C , D ), Student’s t test ( B , F , I ). For the boxplots, the center line indicates the median; the box bounds represent the 25th and 75th percentiles; the whiskers extend to the most extreme data points; and each point represents an independent measurement. .
    Tmp, supplied by Tokyo Chemical Industry, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tmp/tmp/pm41892445-178-0-7
    Average 86 stars, based on 1 article reviews
    tmp - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    86
    Inari Medical Inc o procedimento indicado foi tmp com o sistema clottriever
    Radioscopia demonstra o <t>procedimento</t> de remoção de trombo da veia femoral profunda esquerda. (A) Inserido pela veia femoral comum direita, o introdutor longo 6Fr x 55cm foi posicionado na origem da veia femoral profunda esquerda. Pelo introdutor longo, o cateter Fogarty n° 4 foi inserido, posicionado no segmento distal da veia femoral comum esquerda e insuflado com contraste diluído em solução fisiológica; (B) O <t>sistema</t> <t>ClotTriever®</t> foi posicionado aberto no segmento ilíaco esquerdo e o conjunto introdutor-Fogarty foi tracionado até a veia femoral comum.
    O Procedimento Indicado Foi Tmp Com O Sistema Clottriever, supplied by Inari Medical Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tmp/clottriever+system/pmc13021007-78-0-9
    Average 86 stars, based on 1 article reviews
    o procedimento indicado foi tmp com o sistema clottriever - by Bioz Stars, 2026-10
    86/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) 4 dpci DMSO-treated and TGF-β inhibitor-treated ventricular sections stained for MyHC (CMs, green), mCherry (macrophages, magenta), and DAPI (DNA, blue). Arrowheads point to mpeg1.1 :mCherryF + cells. ( B ) Number of mpeg1.1 :mCherryF + cells per mm 2 injured area in DMSO-treated ( n = 6) and TGFβ inhibitor-treated ( n = 5) ventricles at 4 dpci. ( C ) RT-qPCR analysis of tnfa, il6 and il1b mRNA levels in control (Ctrl) ( n = 4) and TGF-β inhibitor-treated ( n = 5) cryoinjured ventricles at 4 dpci. ( D ) RT-qPCR analysis of ccl20a.3 and cdaa mRNA levels in control (Ctrl) ( n = 5) and TGFβ inhibitor-treated ( n = 5) cryoinjured ventricles at 4 dpci. ( E ) 4 dpci sulf1 +/+ , sulf1 +/+ dexamethasone-treated (DEX), sulf1 −/− and sulf1 −/− dexamethasone-treated ventricular sections stained for pSmad3 (magenta) and DAPI (DNA, blue). Arrowheads point to pSmad3 + cells. ( F ) Number of pSmad3 + cells per mm 2 injured area in sulf1 +/+ ( n = 4), sulf1 +/+ dexamethasone-treated ( n = 4), sulf1 −/− ( n = 5) and sulf1 −/− dexamethasone-treated ( n = 6) ventricles at 4 dpci. ( G ) 30 dpci sulf1 −/− DMSO-treated and sulf1 −/− dexamethasone-treated ventricular sections stained with AFOG for muscle (yellow), collagen (blue), and fibrin (red). ( H ) Percentage representation of groups of different fibrotic area sizes at 30 dpci for cryoinjured sulf1 −/− DMSO-treated ( n = 6) and sulf1 −/− dexamethasone-treated ( n = 5) ventricles. Black dotted lines delineate the area with collagen and fibrin deposits. ( I ) Percentage of collagen/fibrin in fibrotic area in sulf1 −/− DMSO-treated ( n = 6) and sulf1 −/− dexamethasone-treated ( n = 5) ventricles at 30 dpci. Scale bars: 100 µm. White dashed lines delineate the injured area. Statistical tests: Nonparametric Mann–Whitney test ( C , D ), Student’s t test ( B , F , I ). For the boxplots, the center line indicates the median; the box bounds represent the 25th and 75th percentiles; the whiskers extend to the most extreme data points; and each point represents an independent measurement. .

    Journal: EMBO Reports

    Article Title: Sulf1 regulates inflammation via modulation of TGF-β dependent epicardial activation

    doi: 10.1038/s44319-026-00910-5

    Figure Lengend Snippet: ( A ) 4 dpci DMSO-treated and TGF-β inhibitor-treated ventricular sections stained for MyHC (CMs, green), mCherry (macrophages, magenta), and DAPI (DNA, blue). Arrowheads point to mpeg1.1 :mCherryF + cells. ( B ) Number of mpeg1.1 :mCherryF + cells per mm 2 injured area in DMSO-treated ( n = 6) and TGFβ inhibitor-treated ( n = 5) ventricles at 4 dpci. ( C ) RT-qPCR analysis of tnfa, il6 and il1b mRNA levels in control (Ctrl) ( n = 4) and TGF-β inhibitor-treated ( n = 5) cryoinjured ventricles at 4 dpci. ( D ) RT-qPCR analysis of ccl20a.3 and cdaa mRNA levels in control (Ctrl) ( n = 5) and TGFβ inhibitor-treated ( n = 5) cryoinjured ventricles at 4 dpci. ( E ) 4 dpci sulf1 +/+ , sulf1 +/+ dexamethasone-treated (DEX), sulf1 −/− and sulf1 −/− dexamethasone-treated ventricular sections stained for pSmad3 (magenta) and DAPI (DNA, blue). Arrowheads point to pSmad3 + cells. ( F ) Number of pSmad3 + cells per mm 2 injured area in sulf1 +/+ ( n = 4), sulf1 +/+ dexamethasone-treated ( n = 4), sulf1 −/− ( n = 5) and sulf1 −/− dexamethasone-treated ( n = 6) ventricles at 4 dpci. ( G ) 30 dpci sulf1 −/− DMSO-treated and sulf1 −/− dexamethasone-treated ventricular sections stained with AFOG for muscle (yellow), collagen (blue), and fibrin (red). ( H ) Percentage representation of groups of different fibrotic area sizes at 30 dpci for cryoinjured sulf1 −/− DMSO-treated ( n = 6) and sulf1 −/− dexamethasone-treated ( n = 5) ventricles. Black dotted lines delineate the area with collagen and fibrin deposits. ( I ) Percentage of collagen/fibrin in fibrotic area in sulf1 −/− DMSO-treated ( n = 6) and sulf1 −/− dexamethasone-treated ( n = 5) ventricles at 30 dpci. Scale bars: 100 µm. White dashed lines delineate the injured area. Statistical tests: Nonparametric Mann–Whitney test ( C , D ), Student’s t test ( B , F , I ). For the boxplots, the center line indicates the median; the box bounds represent the 25th and 75th percentiles; the whiskers extend to the most extreme data points; and each point represents an independent measurement. .

    Article Snippet: For the TGF-β inhibitor experiment, fish were incubated in system water supplemented with TGF-β inhibitor (Cat. no. SB431542, 50 mg BOC Sciences) or DMSO at a concentration of 10 μM per fish starting 1 day prior to cryoinjuries until 4 dpci when the hearts were extracted.

    Techniques: Staining, Quantitative RT-PCR, Analysis, Control, MANN-WHITNEY

    Radioscopia demonstra o procedimento de remoção de trombo da veia femoral profunda esquerda. (A) Inserido pela veia femoral comum direita, o introdutor longo 6Fr x 55cm foi posicionado na origem da veia femoral profunda esquerda. Pelo introdutor longo, o cateter Fogarty n° 4 foi inserido, posicionado no segmento distal da veia femoral comum esquerda e insuflado com contraste diluído em solução fisiológica; (B) O sistema ClotTriever® foi posicionado aberto no segmento ilíaco esquerdo e o conjunto introdutor-Fogarty foi tracionado até a veia femoral comum.

    Journal: Jornal Vascular Brasileiro

    Article Title: Percutaneous mechanical thrombectomy in a patient with extensive deep vein thrombosis: pioneering surgery in the northern region

    doi: 10.1590/1677-5449.202501162

    Figure Lengend Snippet: Radioscopia demonstra o procedimento de remoção de trombo da veia femoral profunda esquerda. (A) Inserido pela veia femoral comum direita, o introdutor longo 6Fr x 55cm foi posicionado na origem da veia femoral profunda esquerda. Pelo introdutor longo, o cateter Fogarty n° 4 foi inserido, posicionado no segmento distal da veia femoral comum esquerda e insuflado com contraste diluído em solução fisiológica; (B) O sistema ClotTriever® foi posicionado aberto no segmento ilíaco esquerdo e o conjunto introdutor-Fogarty foi tracionado até a veia femoral comum.

    Article Snippet: O procedimento indicado foi TMP com o sistema ClotTriever® (Inari Medical, Inc., EUA), abrangendo os segmentos cavo-ilíaco e fêmoro-poplíteo do MIE.

    Techniques: